IQVIA Holdings (IQV) PT Raised to $290 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
IQVIA Holdings (IQV) Added to BofA US1 List, Medtronic (MDT) Removed
November 18, 2021 5:57 AM ESTIQVIA Holdings (NYSE: IQV) Added to BofA US1 List, Medtronic (NYSE: MDT) Removed
IQVIA Holdings (IQV) PT Raised to $261 at Piper Sandler
November 18, 2021 4:52 AM ESTPiper Sandler analyst Sean Wieland raised the price target on IQVIA Holdings (NYSE: IQV) to $261.00 (from $250.00) while maintaining a Neutral rating.... More
IQVIA Holdings (IQV) PT Raised to $310 at UBS
November 17, 2021 10:01 AM ESTUBS analyst Dan Brennan raised the price target on IQVIA Holdings (NYSE: IQV) to $310.00 (from $298.00) while maintaining a Buy rating.... More
IQVIA Holdings (IQV) PT Raised to $309 at Jefferies
November 17, 2021 7:52 AM ESTJefferies analyst David Windley raised the price target on IQVIA Holdings (NYSE: IQV) to $309.00 (from $300.00) while maintaining a Buy rating.
The analyst commented, "We anticipated raises in medium-term guidance metrics, but got more than we expected. Organic rev at +9% midpoint is 1% more... More
IQVIA Holdings (IQV) PT Raised to $313 at Stifel
November 17, 2021 7:07 AM ESTStifel analyst Shlomo Rosenbaum raised the price target on IQVIA Holdings (NYSE: IQV) to $313.00 (from $304.00) while maintaining a Buy rating.
The analyst commented, "We continue to like the IQV story, and believe the analyst day supports our positive thesis on the shares. The 2022... More
IQVIA Holdings (IQV) PT Raised to $320 at BofA Securities
November 17, 2021 6:02 AM ESTBofA Securities analyst Derik de Bruin raised the price target on IQVIA Holdings (NYSE: IQV) to $320.00 (from $290.00) while maintaining a Buy rating.... More
IQVIA Holdings (IQV) PT Raised to $290 at KeyBanc
November 17, 2021 4:32 AM ESTKeyBanc analyst Donald Hooker raised the price target on IQVIA Holdings (NYSE: IQV) to $290.00 (from $270.00) while maintaining a Overweight rating.... More
NRx Pharmaceuticals (NRXP) Reports Q3 Net Loss of $20.8M; Provides Clinical and Financial Update
November 16, 2021 5:57 AM ESTNRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage, biopharmaceutical company, today provided a business update and financial results for the quarter ended September 30, 2021. NRx will host a conference call Tuesday morning, November 16th, at 8:30 AM Eastern Time to discuss its business update and third-quarter financial results.
Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes before the start of the call by dialing (877) 705-6003 (U.S.), (201) 493-6725 (International) Conference ID: 13724953, or through the webcast link... More
